Listed

Formfactor Inc: Form 10-Q for the period ended Jun 27, 2020

Filed with the SEC on Aug 4, 2020 and accepted by EDGAR at Aug 4, 2020, 14:04 ET.

Share

Management's discussion and analysis

As filed, 36,279 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.

Cautionary Statement Regarding Forward-Looking Statements

This Quarterly Report on Form 10-Q contains forward-looking statements within the meaning of the Securities Exchange Act of 1934 and the Securities Act of 1933, which are subject to risks and uncertainties. The forward-looking statements include statements concerning, among other things, our business strategy, financial and operating results, gross margins, liquidity and capital expenditure requirements and impact of accounting standards. In some cases, you can identify these statements by forward-looking words, such as "may," "might," "will," "could," "should," "expect," "plan," "anticipate," "believe," "estimate," "predict," "intend" and "continue," the negative or plural of these words and other comparable terminology.

The forward-looking statements are only predictions based on our current expectations and our projections about future events. All forward-looking statements included in this Quarterly Report on Form 10-Q are based upon information available to us as of the filing date of this Quarterly Report on Form 10-Q. You should not place undue reliance on these forward-looking statements. We have no obligation to update any of these statements. These forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause our actual results, levels of activity, performance or achievements to differ materially from those expressed or implied by these statements, including risks related to general market trends, the benefits of acquisitions and investments, uncertainties related to COVID-19 and the impact of our responses to it, the interpretation and impacts of changes in export controls and other trade barriers, our ability to execute our business strategy and other risks discussed in the section titled “Risk Factors” and elsewhere in our Annual Report on Form 10-K for the year ended December 28, 2019 and in this Quarterly Report on Form 10-Q. You should carefully consider the numerous risks and uncertainties described under these sections.

The following discussion and analysis should be read in conjunction with our condensed consolidated financial statements and the accompanying notes contained in this Quarterly Report on Form 10-Q. Unless expressly stated or the context otherwise requires, the terms “we,” “our,” “us” and “FormFactor” refer to FormFactor, Inc. and its subsidiaries.

Overview

FormFactor, Inc., headquartered in Livermore, California, is a leading provider of test and measurement solutions. We provide a broad range of high-performance probe cards, analytical probes, probe stations, metrology systems, and thermal sub-systems to both semiconductor companies and scientific institutions. Our products provide electrical and optical information from a variety of semiconductor and electro-optical devices and integrated circuits from research, through development to production. Customers use our products and services to lower production costs, improve yields, and enable development of their complex next-generation products.

We operate in two reportable segments consisting of the Probe Cards segment and the Systems segment. Sales of our probe cards and analytical probes are included in the Probe Cards segment, while sales of our probe stations, metrology systems and thermal sub-systems are included in the Systems segment.

We generated net income of $36.4 million in the first six months of fiscal 2020 as compared to $12.4 million in the first six months of fiscal 2019. The increase in net income was primarily due to increased revenues and good leverage on operating expenses, which only marginally increase on significantly higher operating levels.

Impact of COVID-19

An outbreak of an illness caused by a novel coronavirus in 2019 (“COVID-19”) has resulted in millions of infections and well over six hundred thousand deaths worldwide as of the date of filing this Quarterly Report. COVID-19 continues to spread in many of the regions that we, our customers and our suppliers operate. The COVID-19 pandemic has resulted in significant governmental measures being implemented to control the spread of the virus, including the imposition of stay-at-home and other orders in locations where we have manufacturing and other activities. We experienced a significant disruption to our operations as a result of the COVID-19 pandemic during the last two weeks of our first fiscal quarter of 2020. Through our second quarter we implemented social distancing, contact tracing, and various other measures to enable our manufacturing sites to continue efficient production. While we believe those measures have been largely successful, we continue to monitor the situation closely.

We believe that we operate in a critical infrastructure industry, as defined by the U.S. Department of Homeland Security. This reduces the current and anticipated impacts of the COVID-19 pandemic on our major customers and suppliers, and upon our operations, as compared to companies that are not part of the critical infrastructure. After a temporary suspension of manufacturing to implement safety measures in our California and Oregon locations during our first fiscal quarter of 2020, consistent with federal guidelines and state and local orders, we recommenced manufacturing. We currently continue to operate in all of our manufacturing sites at production levels comparable to those prior to the pandemic, albeit subject to certain safety and related constraints. Our other operations are similarly continuing with substantial work-from-home activities.

If the provisions of governmental health orders or other safety requirements applicable to us or our customers or suppliers continue or become more restrictive for an extended period of time, or if we have occurrences of COVID-19 in any of our facilities, we may experience further disruptions or delays in manufacturing, product design, product development, customer support, manufacturing and sales, and an overall loss of productivity and efficiency.

Even with our continued operations, COVID-19 has had, and may have further, negative impacts on our supply chain, workforce and customers. The continued progression of the COVID-19 pandemic and associated macro-economic, trade-related, and even site-specific restrictions, including but not limited to the effects of any overall global, regional or national economic slowdowns or other economic downturns, increased trade and transport costs, and inability to access customer sites for certain activities could also negatively impact our business or results of operations through new restrictions at our operating locations or at those of our customers or suppliers. As the COVID-19 pandemic is a widespread public health crisis, it is also adversely affecting major economies and financial markets world-wide. A resulting economic downturn can be expected to eventually negatively affect the demand for our products, and contribute to volatile demand and supply conditions affecting the markets for our products.

Governments in several countries where we operate, including the United States, have enacted stabilization and stimulus measures in an effort to counteract some of the impacts of COVID-19. We have benefited and may continue to benefit from some of these measures, although we do not believe those benefits have had or will have a material effect upon our financial results or financial condition. Governments may discontinue, amend, replace or otherwise change or supplement such stabilization and stimulus measures in ways that are difficult to predict, and it is possible that such changes could have a material effect upon our financial results or financial condition, or the financial results or financial condition of our customers or suppliers.

While to date the disruptions in our operations, supply chain and customer demand as a result of the COVID-19 pandemic have been somewhat limited, we believe that the COVID-19 pandemic represents a sustained threat that may eventually give rise to a variety of more significant adverse impacts on our business and financial results. We consider this as a near or longer term trend, although we cannot identify or quantify the specific impacts given current levels of uncertainty and the broad variety of effects that may arise from a pandemic of this magnitude. For a further description of the uncertainties and business risks associated with the COVID-19 pandemic, see the section entitled “Risk Factors” in this Quarterly Report.

Significant Accounting Policies and the Use of Estimates

Management’s Discussion and Analysis and Note 2, Summary of Significant Accounting Policies, to the Consolidated Financial Statements in our 2019 Annual Report on Form 10-K describe the significant accounting estimates and significant accounting policies used in preparation of the Consolidated Financial Statements. Actual results in these areas could differ from management’s estimates. During the six months ended June 27, 2020, there were no significant changes in our significant accounting policies or estimates from those reported in our Annual Report on Form 10-K for the year ended December 28, 2019, which was filed with the Securities and Exchange Commission on February 21, 2020.

Results of Operations

The following table sets forth our operating results as a percentage of revenues for the periods indicated:

Three Months Ended June 27, 2020 June 29, 2019 Six Months Ended June 27, 2020 June 29, 2019
Revenues 100.0% 100.0% 100.0% 100.0%
Cost of revenues 58.1 59.9 58.1 60.1
Gross profit 41.9 40.1 41.9 39.9
Operating expenses:
Research and development 13.3 14.6 13.2 14.7
Selling, general and administrative 14.4 19.0 15.8 19.1
Total operating expenses 27.7 33.6 29.0 33.8
Operating income 14.2 6.5 12.9 6.1
Interest income 0.2 0.5 0.3 0.5
Interest expense (0.1) (0.4) (0.2) (0.4)
Other income (expense), net — 0.1 — —
Income before income taxes 14.3 6.7 13.0 6.2
Provision for income taxes 1.4 1.7 1.6 1.6
Net income 12.9% 5.0% 11.4% 4.6%

Revenues by Segment and Market

(In thousands)

Three Months Ended June 27, 2020 June 29, 2019 Six Months Ended June 27, 2020 June 29, 2019
Probe Cards $133,784 $113,637 $268,499 $221,740
Systems 24,040 24,381 50,078 48,491
$157,824 $138,018 $318,577 $270,231

26

(Dollars in thousands)

Probe Cards Markets: Three Months Ended June 27, 2020 % of Revenues June 29, 2019 % of Revenues $ Change % Change
Foundry & Logic $109,347 69.3% $73,442 53.2% $35,905 48.9%
DRAM 19,052 12.1 36,044 26.1 (16,992) (47.1)
Flash 5,385 3.4 4,151 3.0 1,234 29.7
Systems Market:
Systems 24,040 15.2 24,381 17.7 (341) (1.4)
Total revenues $157,824 100.0% $138,018 100.0% $19,806 14.4%
Six Months Ended
June 27, 2020 % of Revenues June 29, 2019 % of Revenues $ Change % Change
(Dollars in thousands)
Probe Cards Markets:
Foundry & Logic $215,092 67.6% $145,022 53.7% $70,070 48.3%
DRAM 43,748 13.7 64,930 24.0 (21,182) (32.6)
Flash 9,659 3.0 11,788 4.4 (2,129) (18.1)
Systems Market:
Systems 50,078 15.7 48,491 17.9 1,587 3.3
Total revenues $318,577 100.0% $270,231 100.0% $48,346 17.9%

The increase in Foundry & Logic product revenue for the three and six months ended June 27, 2020, compared to the three and six months ended June 29, 2019, was driven principally by increased unit sales to large semiconductor foundries and integrated device manufacturers, as well as increasing our market share with our larger customers as part of our success in diversifying the products we sell to our strategic accounts as they increased manufacturing of new chip designs on leading-edge nodes. Additionally, we began to see an increase in sales due to the demand for 5G handsets and devices.

The decrease in DRAM product revenue for the three and six months ended June 27, 2020, compared to the three and six months ended June 29, 2019, was driven by decreased unit sales as a result of decreased customer demand.

The increase in Flash product revenue for the three months ended June 27, 2020, compared to the three months ended June 29, 2019, was driven by increased unit sales as a result of increased customer demand. This increase helped reduce the overall decrease in the six months ended June 27, 2020, compared to the six months ended June 29, 2019, as our revenue in this market continues to be highly variable.

The increase in Systems product revenue for the six months ended June 27, 2020, compared to the six months ended June 29, 2019, was driven by increased sales of probe stations year over year, which includes an increase in revenue from 300mm stations, and additional contribution from our acquisition of FRT GmbH, partially offset by lower revenue from thermal sub-systems and 200mm stations.

Due to COVID-19, there were various impacts across our segments due to governmental mandates of social distancing. This resulted in a temporary factory shutdown for almost two weeks during our first fiscal quarter of 2020 in certain locations, limiting our manufacturing capacity. These shutdowns negatively affected revenue, especially in our Probes segment.

Revenues by Geographic Region

(Dollars in thousands)

Three Months Ended June 27, 2020 % of Revenue June 29, 2019 % of Revenue Six Months Ended June 27, 2020 % of Revenue June 29, 2019 % of Revenue
China $48,758 30.9% $20,355 14.7% $92,400 29.0% $42,198 15.6%
Taiwan 33,171 21.0% 14,872 10.8% 64,951 20.4% 37,259 13.8%
United States 28,121 17.8% 38,369 27.8% 60,037 18.8% 72,632 26.9%
South Korea 15,113 9.6% 28,171 20.4% 29,201 9.2% 54,894 20.3%
Europe 14,132 9.0% 10,648 7.7% 35,175 11.0% 20,141 7.5%
Japan 10,059 6.4% 16,093 11.7% 18,429 5.8% 26,525 9.8%
Asia-Pacific1 6,500 4.1% 7,683 5.6% 14,363 4.5% 10,946 4.1%
Rest of the world 1,970 1.2% 1,827 1.3% 4,021 1.3% 5,636 2.0%
Total revenues $157,824 100.0% $138,018 100.0% $318,577 100.0% $270,231 100.0%

1 Asia-Pacific includes all countries in the region except China, Japan, South Korea and Taiwan, which are disclosed separately.

Geographic revenue information is based on the location to which we ship the product. For example, if a certain South Korean customer purchases through their U.S. subsidiary and requests the products to be shipped to an address in South Korea, this sale will be reflected in the revenue for South Korea rather than the U.S.

Changes in revenue by geographic region for the three and six months ended June 27, 2020, compared to the three and six months ended June 29, 2019, were primarily attributable to changes in customer demand, shifts in customer regional manufacturing strategies, particularly with our large multinational customers, and product sales mix.

Cost of Revenues and Gross Margins

Cost of revenues consists primarily of manufacturing materials, compensation and benefits, shipping and handling costs, manufacturing-related overhead and amortization of certain intangible assets. Our manufacturing operations rely on a limited number of suppliers to provide key components and materials for our products, some of which are a sole source. We order materials and supplies based on backlog and forecasted customer orders. Tooling and setup costs related to changing manufacturing lots at our suppliers are also included in the cost of revenues. We expense all warranty costs, inventory provisions and amortization of certain intangible assets as cost of revenues.

Our gross profit and gross margin were as follows (dollars in thousands):

Three Months Ended June 27, 2020 June 29, 2019 $ Change % Change
Gross profit $66,167 $55,352 $10,815 19.5%
Gross margin 41.9% 40.1%
Six Months Ended
June 27, 2020 June 29, 2019 $ Change % Change
Gross profit $133,557 $107,873 $25,684 23.8%
Gross margin 41.9% 39.9%

28

Our gross profit and gross margin by segment were as follows (dollars in thousands):

Three Months Ended June 27, 2020 Probe Cards Systems Corporate and Other Total June 29, 2019 Probe Cards Systems Corporate and Other Total
Gross profit $61,523 $10,719 $(6,075) $66,167 $48,492 $12,672 $(5,812) $55,352
Gross margin 46.0% 44.6% —% 41.9% 42.7% 52.0% —% 40.1%
Six Months Ended
June 27, 2020 June 29, 2019
Probe Cards Systems Corporate and Other Total Probe Cards Systems Corporate and Other Total
Gross profit $122,266 $24,053 $(12,762) $133,557 $93,785 $25,688 $(11,600) $107,873
Gross margin 45.5% 48.0% —% 41.9% 42.3% 53.0% —% 39.9%

Probe Cards

For the three and six months ended June 27, 2020, gross profit and gross margins increased compared to the three and six months ended June 29, 2019, primarily due to increased sales and higher factory utilization.

Systems

For the three and six months ended June 27, 2020, gross profit and gross margin decreased compared to the three and six months ended June 29, 2019, primarily as a result of lower sales and less favorable product mix, in particular lower probe station sales.

Corporate and Other

Corporate and Other includes unallocated expenses relating to amortization of intangible assets, share-based compensation, restructuring charges, net, and charges related to inventory stepped up to fair value due to acquisitions which are not used in evaluating the results of, or in allocating resources to, our reportable segments.

Overall

Gross profit and gross margin fluctuate with revenue levels, product mix, selling prices, factory loading and material costs. For the three and six months ended June 27, 2020, compared to the three and six months ended June 29, 2019, gross profit and gross margins have improved, primarily on higher sales.

Cost of revenues included stock-based compensation expense as follows (in thousands):

Three Months Ended June 27, 2020 June 29, 2019 Six Months Ended June 27, 2020 June 29, 2019
Stock-based compensation $901 $964 $1,838 $1,914

Future gross margins may be adversely impacted by lower revenues, unfavorable product mix and lower factory utilization. Our gross margins may also be adversely affected if we are required to record additional inventory write-downs for estimated average selling prices that are below cost or because of a decrease in demand.

Research and Development

(Dollars in thousands)

Three Months Ended June 27, 2020 June 29, 2019 $ Change % Change
Research and development $20,919 $20,074 $845 4.2%
% of revenues 13.3% 14.6%
Six Months Ended
June 27, 2020 June 29, 2019 $ Change % Change
(Dollars in thousands)
Research and development $42,186 $39,797 $2,389 6.0%
% of revenues 13.2% 14.7%

The increase in research and development expenses in the three and six months ended June 27, 2020 when compared to the corresponding period in the prior year was primarily driven by increased headcount combined with higher variable performance based compensation and higher project material costs, partially offset by a decrease in travel due to travel restrictions and decreased stock-based compensation related to the timing of annual grants.

A detail of the changes is as follows (in thousands):

Three Months Ended June 27, 2020 compared to Three Months Ended June 29, 2019 Six Months Ended June 27, 2020 compared to Six Months Ended June 29, 2019
Employee compensation costs 911 2,558
Project material costs 328 263
Depreciation 62 151
Stock-based compensation (193) (273)
Other general operations (263) (310)
$845 $2,389

Research and development included stock-based compensation expense as follows (in thousands):

Three Months Ended June 27, 2020 June 29, 2019 Six Months Ended June 27, 2020 June 29, 2019
Stock-based compensation $1,389 $1,582 $2,828 $3,101

30

Selling, General and Administrative

(Dollars in thousands)

Three Months Ended June 27, 2020 June 29, 2019 $ Change % Change
Selling, general and administrative $22,755 $26,283 $(3,528) (13.4)%
% of revenues 14.4% 19.0%
Six Months Ended
June 27, 2020 June 29, 2019 $ Change % Change
(Dollars in thousands)
Selling, general and administrative $50,448 $51,467 $(1,019) (2.0)%
% of revenues 15.8% 19.0%

The decrease in selling, general and administrative in the three and six months ended June 27, 2020 when compared to the corresponding period in the prior year was primarily due to decreased general operating expenses due to the gain on contingent consideration from the remeasurement of the contingent consideration related to the acquisition of FRT GmbH, as well as decreased travel due to travel restrictions and decreased amortization of intangibles, partially offset by an increase in headcount combined with higher variable performance based compensation, higher stock-based compensation, and higher costs from acquisition of FRT GmbH.

A detail of the changes is as follows (in thousands):

Three Months Ended June 27, 2020 compared to Three Months Ended June 29, 2019 Six Months Ended June 27, 2020 compared to Six Months Ended June 29, 2019
Employee compensation 1,385 3,326
Stock-based compensation 609 1,030
Consulting fees 62 628
Amortization of intangibles (840) (1,697)
Gain on contingent consideration (3,700) (3,700)
General operating expenses (1,044) (606)
$(3,528) $(1,019)

Selling, general and administrative included stock-based compensation expense as follows (in thousands):

Three Months Ended June 27, 2020 June 29, 2019 Six Months Ended June 27, 2020 June 29, 2019
Stock-based compensation $3,352 $2,743 $6,599 $5,569

31

Interest Income and Interest Expense

(Dollars in thousands)

Three Months Ended June 27, 2020 June 29, 2019 Six Months Ended June 27, 2020 June 29, 2019
Interest Income $376 $684 $1,061 $1,264
Weighted average balance of cash and investments $235,888 $177,380 $223,340 $164,416
Weighted average yield on cash and investments 0.81% 2.11% 1.26% 2.07%
Interest Expense $171 $522 $489 $1,117
Average debt outstanding $32,368 $57,253 $38,843 $61,044
Weighted average interest rate on debt 1.92% 4.49% 2.26% 4.50%

Interest income is earned on our cash, cash equivalents, restricted cash and marketable securities. The decrease in interest income for the three and six months ended June 27, 2020 compared with the corresponding period of the prior year was attributable to lower investment yields due to the low interest rate environment partially offset by higher invested balances.

Interest expense primarily includes interest on our term loans, partially offset by income from our interest-rate swap derivative contracts, as well as term loan issuance costs amortization charges. The decrease in interest expense for the three and six months ended June 27, 2020 compared to the same period of the prior year was primarily due to lower outstanding debt balances related to the acquisition of Cascade Microtech in fiscal 2016 as a result of principal payments made, partially offset by additional interest expense related to the term loan originated to finance the acquisition of FRT GmbH in the fourth quarter of 2019 and additional interest expense related to the term loan originated to finance the purchase of a building in the second quarter of 2020.

Other Expense, Net

Other expense, net, primarily includes the effects of foreign currency impact and various other gains and losses.

Provision for Income Taxes

(In thousands, except percentages)

Three Months Ended June 27, 2020 June 29, 2019 Six Months Ended June 27, 2020 June 29, 2019
Provision for income taxes $2,162 $2,290 $4,978 $4,322
Effective tax rate 9.6% 24.8% 12.0% 25.8%

Provision for income taxes reflects the tax provision on our operations in foreign and U.S. jurisdictions, offset by tax benefits from tax credits and the foreign-derived intangible income ("FDII") deduction. We expect the FDII deduction and corresponding benefit to be available after utilizing our previous net operating loss carryforwards, resulting in a decrease in our effective tax rate for the three and six months ended June 27, 2020, compared to the three and six months ended June 29, 2019. Our effective tax rate may vary from period to period based on changes in estimated taxable income or loss by jurisdiction, changes to the valuation allowance, changes to U.S. federal, state or foreign tax laws, changes in ASC 718 stock-based compensation expense/benefit, future expansion into areas with varying country, state, and local income tax rates, deductibility of certain costs and expenses by jurisdiction.

Liquidity and Capital Resources

Capital Resources

Our working capital was $332.2 million at June 27, 2020, compared to $282.5 million at December 28, 2019.

Cash and cash equivalents primarily consist of deposits held at banks and money market funds. Marketable securities primarily consist of U.S. treasuries and corporate bonds. We typically invest in highly-rated securities with low probabilities of default. Our investment policy requires investments to be rated single A or better, and limits the types of acceptable investments, issuer concentration and duration of the investment.

Our cash, cash equivalents and marketable securities totaled approximately $261.1 million at June 27, 2020, compared to $220.9 million at December 28, 2019. We believe that we will be able to satisfy our working capital requirements and scheduled term loan repayments for at least the next twelve months with the liquidity provided by our existing cash, cash equivalents, marketable securities and cash provided by operations. To the extent necessary, we may consider entering into short and long-term debt obligations, raising cash through a stock issuance, or obtaining new financing facilities, which may not be available on terms favorable to us. Our future capital requirements may vary materially from those now planned.

The COVID-19 pandemic has negatively impacted the global economy, disrupted global supply chains and created significant volatility and disruption of financial markets. An extended period of global supply chain and economic disruption could materially affect our business, results of operations, access to sources of liquidity and financial condition. As a result of the current and uncertain future impact of COVID-19, we have taken actions to preserve and improve our liquidity primarily by limiting our exposures to volatile markets and investments, as well as actively working to minimize counterparty risk, for example, by directly investing in securities where the counterparty is the U.S. Government rather than a similar investment where the counterparty is a bank.

If we are unsuccessful in maintaining or growing our revenues, maintaining or reducing our cost structure (in response to a potential reduction in demand due to an industry downturn, COVID-19, or other event), or increasing our available cash through debt or equity financings, our cash, cash equivalents and marketable securities may decline in fiscal 2020.

We utilize a variety of tax planning and financing strategies to manage our worldwide cash and deploy funds to locations where needed. As part of these strategies, we indefinitely reinvest a portion of our foreign earnings. Should we require additional capital in the United States, we may elect to repatriate indefinitely-reinvested foreign funds or raise capital in the United States.

Cash Flows

The following table sets forth our net cash flows from operating, investing and financing activities:

(In thousands)

Six Months Ended June 27, 2020 June 29, 2019
Net cash provided by operating activities $82,447 $55,376
Net cash used in investing activities (20,977) (12,470)
Net cash used in financing activities $(7,265) $(17,037)

Operating Activities

Net cash provided by operating activities for the six months ended June 27, 2020 was primarily attributable to net income of $36.4 million and $39.3 million of net non-cash expenses, offset by changes in operating assets and liabilities, as explained below.

Accounts receivable, net, decreased $11.3 million to $86.6 million at June 27, 2020, compared to $97.9 million at December 28, 2019, as a result of changes in customer sales mix, timing of customer shipments and timing of customer payments.

Inventories, net, increased $4.6 million to $87.8 million at June 27, 2020, compared to $83.3 million at December 28, 2019, as a result of timing of customer demand expected to ship at the beginning of next quarter, as well as smaller impact related to increased inventory purchases to mitigate the impact of COVID-19 on our supply chain.

Accounts payable increased $3.4 million to $44.3 million at June 27, 2020, compared to $40.9 million at December 28, 2019, as a result of timing of vendor payments.

Investing Activities

Net cash used in investing activities for the six months ended June 27, 2020 was primarily related to $36.7 million of cash used in the acquisition of property, plant and equipment, which includes $24.0 million used in the acquisition of a building adjacent to our leased facilities in Livermore, California, partially offset by $15.7 million of net proceeds from sales of marketable securities.

Financing Activities

Net cash used in financing activities for the six months ended June 27, 2020 primarily related to $26.3 million of principal payments made towards the repayment of our term loans and $3.8 million related to tax withholding associated with the net share settlements of our equity awards, partially offset by $18.0 million of proceeds received from the new term loan for our building purchase, as well as $4.9 million of proceeds received from issuances of common stock under our employee stock purchase plan and stock option plans.

Debt

CMI Term Loan

On June 24, 2016, we entered into a senior secured term loan facility of $150 million. The proceeds of the CMI Term Loan were used to finance a portion of the purchase price paid in connection with the Cascade Microtech acquisition in fiscal 2016 and to pay related bank fees and expenses.

The CMI Term Loan bears interest at a rate equal to, at our option, (i) the applicable London Interbank Offered Rate ("LIBOR") rate plus 2.00% per annum or (ii) Base Rate plus 1.00% per annum. We have currently elected to pay interest at 2.00% over the one-month LIBOR rate. Interest payments are payable in monthly installments over a five-year period. The interest rate at June 27, 2020 was 2.41%.

The principal payments on the CMI Term Loan are paid in equal quarterly installments that began June 30, 2016, in an annual amount equal to 5% for year one, 10% for year two, 20% for year three, 30% for year four and 35% for year five. As of June 27, 2020, the balance outstanding pursuant to the CMI Term Loan was $12.5 million. The CMI Term loan was subsequently fully paid as of June 30, 2020.

FRT Term Loan

On October 25, 2019, we entered into a $23.4 million three-year credit facility loan agreement to fund the acquisition of FRT GmbH, which we acquired on October 9, 2019.

The FRT Term Loan bears interest at a rate equal to the Euro Interbank Offered Rate ("EURIBOR") plus 1.75% per annum and will be repaid in quarterly installments of approximately $1.9 million plus interest. The interest rate at June 27, 2020 was 1.36%. As of June 27, 2020, the balance outstanding pursuant to the FRT term loan was $19.6 million.

Building Term Loan

On June 22, 2020, we entered into an $18.0 million 15-year credit facility loan agreement. The proceeds of the Building Term Loan were used to purchase a building adjacent to our leased facilities in Livermore, California.

The Building Term Loan bears interest at a rate equal to the applicable LIBOR rate plus 1.75% per annum. Interest payments are payable in monthly installments over a fifteen-year period. The interest rate at June 27, 2020 was 1.92%. As of June 27, 2020, the balance outstanding pursuant to the Building Term Loan was $18.0 million.

On March 17, 2020, we entered into an interest rate swap agreement to hedge the interest payments on the Building Term Loan for the notional amount of $18.0 million. As future levels of LIBOR over the life of the loan are uncertain, we entered into this interest-rate swap agreement to hedge the exposure in interest rate risks associated with movement in LIBOR rates. By entering into the agreement, we convert a floating rate interest at one-month LIBOR plus 1.75% into a fixed rate interest at 2.75%. The interest rate swap also includes a 0% floor that is effective for one year from the date of the swap. As of June 27, 2020, the notional amount of the loan that is subject to this interest rate swap is $18.0 million.

See Note 6, Debt, of Notes to Condensed Consolidated Financial Statements.

Contractual Obligations and Commitments

The following table summarizes our significant contractual commitments to make future payments in cash under contractual obligations as of June 27, 2020:.

Payments Due In Fiscal Year Remainder 2020 2021 2022 2023 2024 Thereafter Total
Operating leases $3,532 $6,275 $5,084 $4,446 $4,261 $16,150 $39,748
Term loans - principal payments 16,912 8,845 8,873 1,050 1,080 13,368 50,128
Term loans - interest payments (1) 328 537 392 293 273 1,445 3,268
Total $20,772 $15,657 $14,349 $5,789 $5,614 $30,963 $93,144

(1) Represents our minimum interest payment commitments at 1.92% per annum for the Building Term Loan and 1.59% per annum for the FRT Term Loan and 2.18% per annum for the CMI Term Loan.

Off-Balance Sheet Arrangements

Historically, we have not participated in transactions that have generated relationships with unconsolidated entities or financial partnerships, such as entities often referred to as structured finance or special purpose entities, which would have been established for the purpose of facilitating off-balance sheet arrangements or other contractually narrow or limited purposes. As of June 27, 2020, we were not involved in any such off-balance sheet arrangements.

Recent Accounting Pronouncements

See Note 1, Basis of Presentation and New Accounting Pronouncements, of Notes to Condensed Consolidated Financial Statements.

Market risk

As filed, 370 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.

For financial market risks related to changes in interest rates and foreign currency exchange rates, reference is made to Item 7A “Quantitative and Qualitative Disclosures about Market Risk” contained in Part II of our Annual Report on Form 10-K for the fiscal year ended December 28, 2019. Our exposure to market risk has not changed materially since December 28, 2019.

Controls and procedures

As filed, 3,051 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.

Evaluation of Disclosure Controls and Procedures

Based on our management’s evaluation (with the participation of our principal executive officer and principal financial officer), as of the end of the period covered by this report, our principal executive officer and principal financial officer have concluded that our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as amended, (the “Exchange Act”)) are effective to ensure that information required to be disclosed by us in reports that we file or submit under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in Securities and Exchange Commission rules and forms and is accumulated and communicated to our management, including our principal executive officer and principal financial officer, as appropriate to allow timely decisions regarding required disclosure.

Changes in Internal Control over Financial Reporting

There have been no changes in our internal control over financial reporting (as defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act) that occurred during the period covered by this Quarterly Report on Form 10-Q that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

Limitations on the Effectiveness of Controls

Control systems, no matter how well designed and operated, can provide only reasonable, not absolute, assurance that the control systems’ objectives are being met. Further, the design of any control systems must reflect the fact that there are resource constraints, and the benefits of all controls must be considered relative to their costs. Because of the inherent limitations in all control systems, no evaluation of controls can provide absolute assurance that all control issues and instances of fraud, if any, within our company have been detected. These inherent limitations include the realities that judgments in decision making can be faulty and that breakdowns can occur because of a simple error or mistake. Control systems can also be circumvented by the individual acts of some persons, by collusion of two or more people, or by management override of the controls. The design of any system of controls is based, in part, on certain assumptions about the likelihood of future events, and there can be no assurance that any design will succeed in achieving its stated goals under all potential future conditions. Over time, controls may become inadequate because of changes in conditions or deterioration in the degree of compliance with policies or procedures.

CEO and CFO Certifications

We have attached as exhibits to this Quarterly Report on Form 10-Q the certifications of our Chief Executive Officer and Chief Financial Officer, which are required in accordance with the Exchange Act. We recommend that this Item 4 be read in conjunction with the certifications for a more complete understanding of the subject matter presented.

Risk factors

As filed, 10,416 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.

There have been no material changes during the six months ended June 27, 2020 to the risk factors discussed in our Annual Report on Form 10-K for the year ended December 28, 2019 apart from the risk factor described below. If any of the identified risks actually occur, our business, financial condition and results of operations could suffer. The trading price of our common stock could decline and you may lose all or part of your investment in our common stock. The risks and uncertainties described in our Annual Report on Form 10-K for the year ended December 28, 2019 are not the only ones we face. Additional risks that we currently do not know about or that we currently believe to be immaterial may also impair our business operations.

The COVID-19 pandemic has impacted, and is expected to continue to negatively impact, our operations, and those of our important suppliers, business partners and customers.

We are exposed to risks associated with public health crises and outbreaks of contagious diseases, such as the current outbreak of a novel strain of coronavirus ("COVID-19"). To date, COVID-19 has had, and may continue to have, an adverse impact on our operations, our supply chains and our expenses, including as a result of precautionary measures that we take in response to COVID-19.

As a result of the COVID-19 pandemic, we have experienced significant business disruptions, including temporary closures of our facilities, and the facilities of our suppliers and their supply chain partners, and restrictions on our ability to travel and service our products. For example, our corporate headquarters and many of our operations, including much of our manufacturing facilities, are located in California, which instituted health orders applicable to our operations and employees in the region. In other regions where we operate globally, similar health orders have been issued, which have had, and will continue to have, similar affects upon our business. This has the potential to significantly impact our ability to design, produce, deliver and support our products for customers. These unprecedented measures to slow the spread of COVID-19 taken by local and regional governments have had, and will continue to have, a significant negative impact on our operations.

A significant amount of our management resources has been, and will continue to be, focused on mitigating the negative impacts of COVID-19 on our business. This has required, and will continue to require, a substantial investment of time and resources across our enterprise that has delayed, or may continue to delay other valuable activities, such as the development of new technologies, products or capabilities. In addition, many of our employees are working remotely for an extended period which can increase operational risk and cybersecurity risks. If we do not respond appropriately to the COVID-19 pandemic, or if customers do not perceive our response positively, we could suffer damage to our reputation, which could adversely affect our business.

The extent to which the COVID-19 pandemic impacts our operations and those of our important, suppliers, business partners and customers will depend on numerous evolving factors and future developments that we are not able to predict, including but not limited to: the severity of the virus; the duration of the outbreak; governmental, business and other actions (which could include further restrictions on our operations); the ongoing requirements of social distancing and shelter-in-place orders; the impacts on our supply chain; the impact of the pandemic on economic activity; the extent and duration of the effect on business confidence and investments by our customers; the effects of changes to our operations that may continue indefinitely; the health of and the effect on our workforce and our ability to meet our staffing needs, particularly if members of our workforce are exposed or infected; any impairments in the value of our assets which could be recorded as a result of weaker economic conditions; and the potential impacts upon our internal controls, including those over financial reporting, that may result from changes in working environments and other circumstances. All of these circumstances are highly uncertain and cannot be predicted. In addition, the circumstances which give rise to new or existing infectious diseases becoming epidemics or pandemics with potentially similar impacts are expected to persist.

Further, we obtain some of the components and materials used in our products from a sole source or a limited group of suppliers, and in some cases alternative sources are not readily available. The COVID-19 pandemic may heighten the risks posed by our dependence upon sole or limited source suppliers to the extent that the pandemic could disrupt the operations of one or more of these suppliers, resulting in an inability to obtain an adequate supply of materials, late deliveries or poor component quality while we seek to identify and qualify alternative suppliers. Such disruptions could disrupt our operations and result an adverse impact to our results of operations, cash flows and financial position.

Adverse global, regional and national economic conditions resulting from the COVID-19 pandemic could have a negative effect on our business, results of operations and financial condition and liquidity

The COVID-19 pandemic has adversely affected, and may continue to adversely affect, national, regional and global economies and financial markets. Although the long-term macroeconomic effects of the pandemic cannot be predicted with certainty, the continued progression or persistence of the pandemic may result in global, regional or national economic slowdowns or other economic downturns. Such downturns could curtail or delay spending by businesses and consumers which may ultimately result in reductions in the demand for our products and greater volatility in demand and supply conditions. The COVID-19 pandemic has also created significant volatility, uncertainty and disruption in global credit and financial markets. Such impacts, as well as any further disruptions to or reductions in the availability of credit or other sources of capital as the pandemic continues to progress or persist, could also adversely affect our ability to access capital on favorable terms to meet our objectives. Any of these factors could have a material adverse impact on our business, results of operations, financial condition and cash flows.

In addition, governments in several countries where we operate, including the United States, have enacted stabilization and stimulus measures in an effort to counteract some of the impacts of COVID-19. The demand and business environments in which we operate have benefited from some of these measures. Any discontinuations, reductions, or other changes to such stabilization and stimulus programs may harm our customers’ or suppliers’ financial results and financial condition, and could also have an adverse macroeconomic impact that may lead to reductions in the demand for our products. Even if left unchanged or expanded, such stimulus and stabilization measures may fail over the long term to mitigate the adverse economic effects of the pandemic, and may fail to prevent or exacerbate any long-term economic downturns.

As a result of the uncertain scope and duration of the COVID-19 pandemic and the uncertain timing of any national, regional or global recovery and economic normalization, we are unable to estimate the long-term impacts on our operations and financial results. As a result, we may decide to limit or refrain from providing financial guidance in the manner we have done in prior reporting periods, which could negatively affect our stock price.

Increasingly restrictive export regulations and other trade barriers may materially harm our business.

Sales of our products to customers outside of the United States represent a significant part of our past and anticipated revenues, including sales involving exports from the United States to China. There is a continuing trend of increasing tariffs and trade controls affecting exports to China. For example, the U.S. Department of Commerce, Bureau of Industry and Security, has recently amended the U.S. Export Administration Regulations to expand license requirements on exports to entities in China that may support military end uses. These rules expand export license requirements on a broader set of items from the U.S., including many of our products and for a broader set of customers in China and elsewhere. There is no assurance that we will obtain any such licenses on a timely basis or at all. There also remains considerable uncertainty regarding the interpretation and implementation of these rules. These and other regulatory changes could materially and negatively affect our future sales and operating results.

We rely on the security and integrity of our electronic data systems and our business can be damaged by disruptions, security breaches or other compromises of these systems.

We rely on electronic data systems to operate and manage our business and to process, maintain, and safeguard information, including information belonging to our customers, partners, and personnel. These systems may be subject to failures or disruptions as a result of, among other things, natural disasters, accidents, power disruptions, telecommunications failures, new system implementations, acts of terrorism or war, physical security breaches, computer viruses or other cyber security attacks. For example, in June 2020, we discovered a data breach incident involving malware and related behaviors that resulted in unauthorized access to our information technology systems. Although we do not believe this incident had any significant impacts on our production and ordinary course operations, such incidents or other system failures or disruptions could subject us to downtime and delays, compromise or loss of sensitive or proprietary information, destruction or corruption of data, financial losses from remedial actions, breaches of obligations to third parties under privacy laws or contracts, or damage to our reputation or customer relationships. Any of the foregoing could have a material adverse effect on our business, operating results and financial condition.

Figures reported in this filing

Standardized line items from the XBRL in this filing, for the period ended 2020-06-27. Comparative periods it repeats are left out.

Figures reported in this filing
Line itemPeriodValueXBRL concept
Revenue3 months2020-03-29 to 2020-06-27$157.8mus-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
Revenue6 months2019-12-29 to 2020-06-27$318.6mus-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
Cost of revenue3 months2020-03-29 to 2020-06-27$91.7mus-gaap:CostOfGoodsAndServicesSold
Cost of revenue6 months2019-12-29 to 2020-06-27$185.0mus-gaap:CostOfGoodsAndServicesSold
Gross profit3 months2020-03-29 to 2020-06-27$66.2mus-gaap:GrossProfit
Gross profit6 months2019-12-29 to 2020-06-27$133.6mus-gaap:GrossProfit
Research and development3 months2020-03-29 to 2020-06-27$20.9mus-gaap:ResearchAndDevelopmentExpense
Research and development6 months2019-12-29 to 2020-06-27$42.2mus-gaap:ResearchAndDevelopmentExpense
Selling, general and administrative3 months2020-03-29 to 2020-06-27$22.8mus-gaap:SellingGeneralAndAdministrativeExpense
Selling, general and administrative6 months2019-12-29 to 2020-06-27$50.4mus-gaap:SellingGeneralAndAdministrativeExpense
Operating income3 months2020-03-29 to 2020-06-27$22.5mus-gaap:OperatingIncomeLoss
Operating income6 months2019-12-29 to 2020-06-27$40.9mus-gaap:OperatingIncomeLoss
Interest expense3 months2020-03-29 to 2020-06-27$171.0kus-gaap:InterestExpense
Interest expense6 months2019-12-29 to 2020-06-27$489.0kus-gaap:InterestExpense
Income tax3 months2020-03-29 to 2020-06-27$2.2mus-gaap:IncomeTaxExpenseBenefit
Income tax6 months2019-12-29 to 2020-06-27$5.0mus-gaap:IncomeTaxExpenseBenefit
Net income3 months2020-03-29 to 2020-06-27$20.5mus-gaap:NetIncomeLoss
Net income6 months2019-12-29 to 2020-06-27$36.4mus-gaap:NetIncomeLoss
Diluted EPS3 months2020-03-29 to 2020-06-27$0.26us-gaap:EarningsPerShareDiluted
Diluted EPS6 months2019-12-29 to 2020-06-27$0.46us-gaap:EarningsPerShareDiluted
Basic EPS3 months2020-03-29 to 2020-06-27$0.27us-gaap:EarningsPerShareBasic
Basic EPS6 months2019-12-29 to 2020-06-27$0.48us-gaap:EarningsPerShareBasic
Diluted shares (weighted)3 months2020-03-29 to 2020-06-2778,861,000 sharesus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
Diluted shares (weighted)6 months2019-12-29 to 2020-06-2778,710,000 sharesus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
Operating cash flow6 months2019-12-29 to 2020-06-27$82.4mus-gaap:NetCashProvidedByUsedInOperatingActivities
Capital expenditure6 months2019-12-29 to 2020-06-27$36.7mus-gaap:PaymentsToAcquirePropertyPlantAndEquipment
Cash and equivalentsAt period end2020-06-27$199.9mus-gaap:CashAndCashEquivalentsAtCarryingValue
Current assetsAt period end2020-06-27$455.4mus-gaap:AssetsCurrent
Total assetsAt period end2020-06-27$884.2mus-gaap:Assets
Current liabilitiesAt period end2020-06-27$123.2mus-gaap:LiabilitiesCurrent
Total liabilitiesAt period end2020-06-27$193.5mus-gaap:Liabilities
Long-term debtAt period end2020-06-27$28.7mus-gaap:LongTermDebtNoncurrent
Current portion of debtAt period end2020-06-27$21.3mus-gaap:LongTermDebtCurrent
Shareholders' equityAt period end2020-06-27$690.7mus-gaap:StockholdersEquity

Source: SEC EDGAR, the filing index for accession 0001039399-20-000073. Last ingested by Listed: Nov 13, 2026, 15:19 ET. Listed shows no prices and gives no investment advice.